Search Orphan Drug Designations and Approvals
-
| Generic Name: | synthetic polymer PEG conjugated to a phospholipid anchor (2-dipalmitoyl-sn-glycerol-3-phosphatidylethanolamine) |
|---|---|
| Date Designated: | 10/17/2022 |
| Orphan Designation: | Prevention of ischemia reperfusion injury during solid organ transplantation |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
iCoat Medical AB WeWork, c/o iCoat Medical AB Malmskillnadsgatan 32 Stockholm 111 51 Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







